4808 Results

People

  1. Travis
    Travis
  2. Berger
    Berger
  3. Hudis
    Hudis
  4. Ladanyi
    Ladanyi
  5. Arcila
    Arcila
  6. Reis-Filho
    Reis-Filho
  7. Weigelt
    Weigelt
  8. Giralt
    Giralt
  9. Levine
    Levine
  10. Motzer
    Motzer

Groups

  1. Department of Medicine (1855)
  2. GSK Faculty (1116)
  3. Solid Tumor Oncology Division (1035)
  4. Surgery (883)
  5. Survivorship Research (752)
  6. Center for Hematologic Malignancies (746)
  7. Department of Pathology and Laboratory Medicine (714)
  8. Hematologic Malignancies, Division of (683)
  9. Population Sciences Research Program (601)
  10. Sloan Kettering Institute Faculty (586)
  1. "2015"
Formats
  1. Journal Article (2716)
  2. Meeting Abstract (1680)
  3. Book Section (364)
  4. Conference Paper (26)
  5. Book Whole (19)
  6. Review (2)
  7. Research Letter (1)
Groups
  1. Department of Medicine (1855)
  2. GSK Faculty (1116)
  3. Solid Tumor Oncology Division (1035)
  4. Surgery (883)
  5. Survivorship Research (752)
  6. Center for Hematologic Malignancies (746)

More Groups

People
  1. William Travis (102)
  2. Michael Berger (96)
  3. Clifford Hudis (85)
  4. Marc Ladanyi (79)
  5. Jedd Wolchok (68)
  6. Britta Weigelt (67)

More People

Years
  1. 2015 (4808)
Publications
  1. Journal of Clinical Oncology (475)
  2. Blood (224)
  3. Cancer Research (168)
  4. Modern Pathology (125)
  5. Laboratory Investigation (112)
  6. International Journal of Radiation Oncology, Biology, Physics (91)

More Publications

Publishers
  1. Elsevier Inc. (581)
  2. American Society of Clinical Oncology (508)
  3. Springer (380)
  4. Nature Publishing Group (301)
  5. American Association for Cancer Research (263)
  6. American Society of Hematology (228)

More Publishers

Results (4808)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Ibrutinib plus rituximab in treatment-naive patients with follicular lymphoma: Results from a multicenter, phase 2 study
    Meeting Abstract

    Fowler, N.; Nastoupil, L.; de Vos, S.; Knapp, M.; Flinn, I. W.; Chen, R.; Advani, R. H.; Bhatia, S.; Martin, P.; Mena, R.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • North American leukemia, intergroup phase III randomized trial of single agent clofarabine as induction and post-remission therapy, and decitabine as maintenance therapy in newly-diagnosed acute myeloid leukemia in older adults (age >= 60 years): A trial of the ECOG-ACRIN Cancer Research Group (E2906)
    Meeting Abstract

    Foran, J. M.; Sun, Z. X.; Claxton, D. F.; Lazarus, H. M.; Thomas, M. L.; Melnick, A.; Levine, R. L.; Paietta, E.; Arber, D.; Zhang, Y. M.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Diverse and targetable kinase alterations drive histiocytic neoplasms
    Meeting Abstract

    Durham, B. H.; Diamond, E. L.; Haroche, J.; Yao, Z.; Ma, J.; Parikh, S. A.; Choi, J.; Kim, E.; Cohen-Aubart, F.; Lee, S. C. W.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • B-lymphoid transcription factors restrict glycolytic energy supply for oncogenic signaling
    Meeting Abstract

    Chan, L. N.; Chen, Z. S.; Braas, D.; Geng, H. M.; Hurtz, C.; Shojaee, S.; Cazzaniga, V.; Ng, C.; Ernst, T.; Hochhaus, A.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Feasibility of interim PET-adapted therapy in HIV-positive patients with advanced Hodgkin lymphoma (HL): Sub-analysis of SWOG S0816 phase 2 trial
    Meeting Abstract

    Danilov, A. V.; Li, H. L.; Press, O. W.; Shapira, I.; Swinnen, L. J.; Noy, A.; Reid, E.; Smith, S. M.; Friedberg, J. W.
    Blood (2015)

    Fulltext@MSK | Save
  • Molecular profiling and relationship with clinical response in patients with IDH1 mutation-positive hematologic malignancies receiving AG-120, a first-in-class potent inhibitor of mutant IDH1, in addition to data from the completed dose escalation portion of the phase 1 study
    Meeting Abstract

    DiNardo, C.; de Botton, S.; Pollyea, D. A.; Stein, E. M.; Fathi, A. T.; Roboz, G. J.; Collins, R.; Swords, R. T.; Flinn, I. W.; Altman, J. K.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Risk-adapted therapy in adults with Burkitt lymphoma: Preliminary report of a multicenter prospective phase II study of DA-EPOCH-R
    Meeting Abstract

    Dunleavy, K.; Noy, A.; Abramson, J. S.; LaCasce, A. S.; Link, B. K.; Parekh, S.; Jagadeesh, D.; Bierman, P. J.; Mitsuyasu, R. T.; Battini, R.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Alemtuzumab-cyclosporine versus tacrolimus-methotrexate-sirolimus for graft-versus-host disease prophylaxis in reduced intensity allogeneic hematopoietic stem cell transplantation from unrelated donors: Final results of a randomized trial
    Meeting Abstract

    Curtis, L. M.; Pavletic, S. Z.; Salit, R. B.; Shaffer, B. C.; Steinberg, S. M.; Wilder, J. S.; Pirsl, F.; Blacklock-Schuver, B.; Hsu, J.; Hughes, T. E.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Outcomes of inferior vena cava filter placement in a large population of cancer patients diagnosed with pulmonary embolism: Risk for recurrent venous thromboembolism, survival, and filter-related complications
    Meeting Abstract

    Coombs, C. C.; Kuk, D.; Devlin, S.; Siegelbaum, R.; Parameswaran, R.; Mantha, S.; Soff, G. A.
    Blood (2015)

    Fulltext@MSK | Save
  • PD-1 blockade with pembrolizumab in patients with classical Hodgkin lymphoma after brentuximab vedotin failure: Safety, efficacy, and biomarker assessment
    Meeting Abstract

    Armand, P.; Shipp, M. A.; Ribrag, V.; Michot, J. M.; Zinzani, P. L.; Gutierrez, M.; Snyder, E.; Ricart, A. D.; Balakumaran, A.; Moskowitz, C. H.
    Blood (2015)

    Fulltext@MSK | Save